Journal of Neuroimmunology
Volume 222, Issue 1 , Pages 82-86 , May 2010

Alternative splicing of interleukin-7 (IL-7) and interleukin-7 receptor alpha (IL-7Rα) in peripheral blood from patients with multiple sclerosis (MS)

  • Lalit Rane

      Affiliations

    • Department of Microbiology, Tumor and Cell Biology (MTC), Nobels Väg 18, Karolinska Institutet, SE-17182 Stockholm, Sweden
    • Smittskyddsinstitutet, Translational Immunology (TRIM), Swedish Institute for Infectious Disease Control, SE-17182 Stockholm, Sweden
    • ,
  • Nalini Vudattu

      Affiliations

    • Department of Microbiology, Tumor and Cell Biology (MTC), Nobels Väg 18, Karolinska Institutet, SE-17182 Stockholm, Sweden
    • ,
  • Kasia Bourcier

      Affiliations

    • Immune Tolerance Network, Dept of Medicine, University of California, San Francisco, CA, USA
    • ,
  • Eva Graniar

      Affiliations

    • Department of Clinical Neurosciences, Karolinska Institute, Stockholm, Sweden
    • ,
  • Jan Hillert

      Affiliations

    • Department of Clinical Neurosciences, Karolinska Institute, Stockholm, Sweden
    • ,
  • Vicki Seyfert

      Affiliations

    • Immune Tolerance Network, Dept of Medicine, University of California, San Francisco, CA, USA
    • ,
  • M J Maeurer

      Affiliations

    • Department of Microbiology, Tumor and Cell Biology (MTC), Nobels Väg 18, Karolinska Institutet, SE-17182 Stockholm, Sweden
    • Smittskyddsinstitutet, Translational Immunology (TRIM), Swedish Institute for Infectious Disease Control, SE-17182 Stockholm, Sweden
    • Corresponding Author InformationCorresponding author. Department of Microbiology, Tumor and Cell Biology (MTC) and SMI, Nobels Väg 18, SE-171 82 Stockholm, Sweden. Tel.: +46 8 457 2650; fax: +46 8 33 74 60.

Received 10 October 2009 ,Revised 27 January 2010 ,Accepted 15 February 2010.

References 

  1. Al-Rawi MA, Rmali K, Mansel RE, Jiang WG. Interleukin 7 induces the growth of breast cancer cells through a wortmannin-sensitive pathway. Br. J. Surg. 2004;91:61–68
  2. Atamas SP, Choi J, Yurovsky VV, White B. An alternative splice variant of human IL-4, IL-4 delta 2, inhibits IL-4-stimulated T cell proliferation. J. Immunol. 1996;156:435–441
  3. Benjamin D, Sharma V, Knobloch TJ, Armitage RJ, Dayton MA, Goodwin RG. B cell IL-7. Human B cell lines constitutively secrete IL-7 and express IL-7 receptors. J. Immunol. 1994;152:4749–4757
  4. Booth DR, Arthur AT, Teutsch SM, Bye C, Rubio J, Armati PJ, et al. Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis. J. Mol. Med. 2005;83:822–830
  5. Fry TJ, Mackall CL. Interleukin-7: from bench to clinic. Blood. 2002;99:3892–3904
  6. Goodwin RG, Lupton S, Schmierer A, Hjerrild KJ, Jerzy R, Clevenger W, et al. Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells. Proc. Natl. Acad. Sci. U. S. A. 1989;86:302–306
  7. Gregory SG, Schmidt S, Seth P, Oksenberg JR, Hart J, Prokop A, et al. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat. Genet. 2007;39:1083–1091
  8. Heaney ML, Golde DW. Soluble cytokine receptors. Blood. 1996;87:847–857
  9. Houseley J, Tollervey D. The many pathways of RNA degradation. Cell. 2009;136:763–776
  10. Korte A, Moricke A, Beyermann B, Kochling J, Taube T, Kebelmann-Betzing C, et al. Extensive alternative splicing of interleukin-7 in malignant hematopoietic cells: implication of distinct isoforms in modulating IL-7 activity. J. Interferon Cytokine Res. 1999;19:495–503
  11. Krawczenko A, Kieda C, Dus D. The biological role and potential therapeutic application of interleukin 7. Arch. Immunol. Ther. Exp. (Warsz). 2005;53:518–525
  12. Lundmark F, Duvefelt K, Iacobaeus E, Kockum I, Wallstrom E, Khademi M, et al. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat. Genet. 2007;39:1108–1113
  13. Rose T, Lambotte O, Pallier C, Delfraissy JF, Colle JH. Identification and biochemical characterization of human plasma soluble IL-7R: lower concentrations in HIV-1-infected patients. J. Immunol. 2009;182:7389–7397
  14. Scupoli MT, Perbellini O, Krampera M, Vinante F, Cioffi F, Pizzolo G. Interleukin 7 requirement for survival of T-cell acute lymphoblastic leukemia and human thymocytes on bone marrow stroma. Haematologica. 2007;92:264–266
  15. Sorg RV, McLellan AD, Hock BD, Fearnley DB, Hart DN. Human dendritic cells express functional interleukin-7. Immunobiology. 1998;198:514–526
  16. Tsytsikov VN, Yurovsky VV, Atamas SP, Alms WJ, White B. Identification and characterization of two alternative splice variants of human interleukin-2. J. Biol. Chem. 1996;271:23055–23060
  17. Vudattu NK, Kuhlmann-Berenzon S, Khademi M, Seyfert V, Olsson T, Maeurer MJ. Increased numbers of IL-7 receptor molecules on CD4+CD25-CD107a+T-cells in patients with autoimmune diseases affecting the central nervous system. PLoS ONE. 2009;4:e6534
  18. Vudattu NK, Magalhaes I, Hoehn H, Pan D, Maeurer MJ. Expression analysis and functional activity of interleukin-7 splice variants. Genes Immun. 2009;10:132–140
  19. Yamanaka K, Clark R, Rich B, Dowgiert R, Hirahara K, Hurwitz D, et al. Skin-derived interleukin-7 contributes to the proliferation of lymphocytes in cutaneous T-cell lymphoma. Blood. 2006;107:2440–2445

PII: S0165-5728(10)00063-9

doi: 10.1016/j.jneuroim.2010.02.014

Journal of Neuroimmunology
Volume 222, Issue 1 , Pages 82-86 , May 2010

Article Tools

* Image Usage & Resolution